Increased risk of hair loss with GLP-1 receptor agonists: TriNetX cohort study (n=547,993)
JCI Insight (2018) 3(23):115
How is compounded semaglutide prepared
A., Akinwande, A
Common side effects include nausea, constipation, diarrhea, reflux, bloating, reduced appetite, and abdominal discomfort
According to the FDA's approval, the eligibility criteria are as follows: For Adults: A Body Mass Index (BMI) of 30 kg/m or greater (defined as obesity), OR a BMI of 27 kg/m or greater (defined as overweight) with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol